Oxford BioDynamics Plc announced audited consolidated earnings results for the year ended September 30, 2016. For the year, the company reported revenue of £1.091 million against £0.702 million a year ago. Operating loss was £2.328 million against £1.608 million a year ago. Loss before tax was £2.074 million against £1.370 million a year ago. Loss for the year from continuing operations was £1.730 million against £1.005 million a year ago. Loss attributable to owners of the company was £1.730 million against £1.005 million a year ago. Basic and diluted loss per share from continuing operations was 2.1 pence against 1.3 pence a year ago. Net cash used in operating activities was £1.348 million against £1.229 million a year ago. Purchases of property, plant and equipment was £0.208 million against £0.523 million a year ago. Adjusted operating loss was £1.9 million against £1.6 million a year ago. Adjusted loss per share was 1.6 pence against 1.3 pence a year ago, excluding one-off IPO costs of £0.4 million.